Your browser doesn't support javascript.
loading
MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy.
Wang, Jiachen; Shang, Zhen; Wang, Jue; Xu, Jinhuan; Li, Weigang; Guan, Yuqi; Yang, Li; Zhang, Wei; Shen, Kefeng; Zhang, Meilan; Wang, Jin; Chen, Liting; Li, Qinlu; He, Cheng; Wang, Na; Huang, Liang; Xiao, Yi; Xiao, Min; Zhou, Jianfeng.
Afiliación
  • Wang J; Department of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Shang Z; Department of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Wang J; Department of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Xu J; Department of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Li W; Department of Orthopedics, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Guan Y; Department of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Yang L; Department of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Zhang W; Department of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Shen K; Department of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Zhang M; Department of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Wang J; Department of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Chen L; Department of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Li Q; Department of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • He C; Department of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Wang N; Department of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Huang L; Department of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.
  • Xiao Y; Department of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China xiaomin@tjh.tjmu.edu.cn yixiao@tjh.tjmu.edu.cn.
  • Xiao M; Department of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China xiaomin@tjh.tjmu.edu.cn yixiao@tjh.tjmu.edu.cn.
  • Zhou J; Department of Hematology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, Hubei, China.
J Immunother Cancer ; 9(6)2021 06.
Article en En | MEDLINE | ID: mdl-34078654
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Variación Genética / Inmunoterapia Adoptiva / Linfoma de Células B Grandes Difuso Límite: Adult / Humans / Male Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Variación Genética / Inmunoterapia Adoptiva / Linfoma de Células B Grandes Difuso Límite: Adult / Humans / Male Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido